AstraZeneca PLC

Anglo-Swedish pharmaceutical concern AstraZeneca will float shares on the New York Stock Exchange, it <a href="https://news.cision.com/se/astrazeneca/r/astrazeneca-to-harmonise-its-listing-structure-across-the-london-stock-exchange--nasdaq-stockholm-an%2Cc4241238?utm_source=chatgpt.com">said </a>Monday, Sept. 29. These securities will replace depositary receipts, which are now traded on the Nasdaq exchange.

AstraZeneca to float in New York but retain London listing

Novo Nordisk A/S

Roche Holding AG

European pharma giants have a chance to avoid prohibitive duties on branded drugs, says JPMorgan Chase

Pharma stocks in Europe reacted weakly to Trump's threats of new duties

The Coca-Cola Company

Chewy, Inc.

Eli Lilly and Company

Steve Cohen, founder of hedge fund Point72 Asset Management, believes the current upturn in the markets looks unreliable. He estimates the likelihood of a recession at nearly 45%, and he says indexes could yet return to April lows. "We're all somewhat dependent on news right now, and that's a tricky way to manage money," the investor says.

Cohen's Shield: 10 stocks the Point72 founder uses to protect his portfolio from overheating

Pfizer Inc.

The US President sent letters to 17 pharmaceutical market leaders

Pharma stocks plummet after Trump's demand for price cuts. Should we be worried?

The owner of Figma, an online editor for creating websites and mobile applications that Adobe tried to buy for $20 billion, may launch an IPO as early as July. Surgical imaging software developer Brainlab has postponed its first major IPO of 2025 in Germany. AstraZeneca, the UK's most expensive public company, is thinking of moving its listing from London to the US. The main IPO market events of the week are in our selection.

A Google supplier and a startup missed by Adobe are going public: what's important about the IPO by July 6

At least a dozen companies are looking for a way to reduce muscle mass loss when taking weight loss drugs

#AstraZeneca: 6

AstraZeneca to float in New York but retain London listing

Pharma stocks in Europe reacted weakly to Trump's threats of new duties

Cohen's Shield: 10 stocks the Point72 founder uses to protect his portfolio from overheating

Pharma stocks plummet after Trump's demand for price cuts. Should we be worried?

A Google supplier and a startup missed by Adobe are going public: what's important about the IPO by July 6

Eli Lilly is entering a market valued at $30 billion, can it beat the competition?